Tolerability, Efficacy, and PK of ZSP1601 in Patients With Non-Alcoholic Steatohepatitis (NASH)

Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2020
Double‐blind, randomized, placebo‐controlled study to explore the safety, tolerability PK characteristics and early efficacy of ZSP1601 tablets in patients with non‐alcoholic steatohepatitis (NASH).
Epistemonikos ID: 7b4d67683b6c8b31cd8bacda8f814363093f8795
First added on: May 06, 2024